Pediatric Dermatology Treatment Market Size

  • Report ID: 3742
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Pediatric Dermatology Treatment Market size is expected to register around 9.3% CAGR during the forecast period i.e., between 2025-2037.

The growth of the market can be attributed to the increasing prevalence of skin disorders around the world, and rise in awareness levels associated with the progression of dermatology diseases. As per the World Psoriasis Day consortium, as of 2020, 125 million people around the world were suffering from psoriasis, which is about 2 to 3 percent of the total population. Along with these, growing incidences of weakened immune systems among children as a result of sedentary lifestyle is also expected to drive significant growth to the market in the forthcoming years. Furthermore, high healthcare expenditures in developed countries, and surge in technological advancements to develop improved treatment options for skin diseases are projected to offer lucrative opportunities for pediatric dermatology treatment market growth in the near future.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Pediatric Dermatology Treatment Market size is expected to register around 9.3% CAGR during the forecast period i.e., between 2025-2037.

The market growth is driven by increasing prevalence of skin disorders worldwide, and rising awareness levels associated with the progression of dermatology diseases.

Asia Pacific industry is anticipated to hold largest revenue share by 2037, impelled by large patient pool and growing number of incidences of dermatology diseases among children in the region.

The major players in the market are Novartis AG, Amgen Inc., AbbVie Inc., Almirall SA, Bausch Health Companies Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos